Casdin Capital, LLC Invitae Corp Transaction History

Casdin Capital, LLC

$1.24 Billion
Q1 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.2 - $2.73 $9.6 Million - $21.8 Million	-8,000,000 Reduced 88.51%	1,038,388 $1.4 Million
Q4 2022 Feb 14, 2023	BUY	$1.71 - $3.61 $13.5 Million - $28.6 Million	7,912,500 Added 702.78%	9,038,388 $16.8 Million
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $166,250 - $755,125	87,500 Added 8.43%	1,125,888 $2.77 Million
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $23.8 Million - $101 Million	-11,165,281 Reduced 91.49%	1,038,388 $2.53 Million
Q1 2021 May 17, 2021	SELL	$33.06 - $56.93 $3.12 Million - $5.37 Million	-94,369 Reduced 0.77%	12,203,669 $466 Million

Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $128 Million - $187 Million	3,264,095 Added 36.13%	12,298,038 $514 Million
Q2 2020 Aug 14, 2020	BUY	$11.71 - $30.29 $65.1 Million - $168 Million	5,555,555 Added 159.72%	9,033,943 $274 Million
Q1 2020 May 15, 2020	SELL	$7.64 - $27.5 $1.22 Million - $4.4 Million	-160,000 Reduced 4.4%	3,478,388 $47.6 Million
Q4 2019 Feb 14, 2020	SELL	$15.02 - $20.57 $3 Million - $4.11 Million	-200,000 Reduced 5.21%	3,638,388 $58.7 Million
Q3 2019 Nov 12, 2019	BUY	$18.85 - $27.5 $52.8 Million - $77 Million	2,800,000 Added 269.65%	3,838,388 $74 Billion
Q3 2019 Nov 12, 2019	SELL	$18.85 - $27.5 $52.8 Million - $77 Million	-2,800,000 Reduced 72.95%	1,038,388 $83.6 Billion
Q2 2019 Aug 13, 2019	BUY	$17.37 - $26.27 $28.5 Million - $43 Million	1,638,388 Added 74.47%	3,838,388 $0
Q1 2019 May 15, 2019	SELL	$10.65 - $25.75 $2.13 Million - $5.15 Million	-200,000 Reduced 8.33%	2,200,000 $51.5 Million
Q3 2018 Nov 14, 2018	BUY	$7.54 - $18.31 $18.1 Million - $43.9 Million	2,400,000 New	2,400,000 $40.2 Million

Others Institutions Holding NVTA

# of Institutions

Shares Held

7.66M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.

Account